[Form 4] Orchestra BioMed Holdings, Inc. Insider Trading Activity
Hochman David P reported acquisition or exercise transactions in a Form 4 filing for OBIO.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
Hochman David P reported acquisition or exercise transactions in a Form 4 filing for OBIO. The filing lists transactions totaling 504,000 shares. Following the reported transactions, holdings were 1,076,467 shares.
Insider Trade Summary
Grant/Award: 504,000 shares
Grant/Award
6 txns
Insider
Hochman David P
Role
See Remarks
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock, par value $0.0001 per share ("Common Stock") | 504,000 | $0.00 | $0.00 |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
Holdings After Transaction:
Common Stock, par value $0.0001 per share ("Common Stock") — 1,076,467 shares (Direct);
Common Stock — 439,482 shares (Indirect, By the DPH 2008 Trust);
Common Stock — 2,000 shares (Indirect, By the Solomon Ascher Hochman 2019 Trust);
Common Stock — 2,000 shares (Indirect, By the Hannah Hochman 2019 Trust);
Common Stock — 2,000 shares (Indirect, By the Judah Herman Hochman 2019 Trust);
Common Stock — 3,140 shares (Indirect, By the NSH 2008 Family Trust)
Footnotes (1)
- F1. Represents an award of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of Common Stock. The RSUs vest over a three-year period as follows: (i) 25% of the shares will vest 18 months after February 12, 2026 (the "Issue Date"), (ii) 25% of the shares will vest 24 months after the Issue Date, (iii) 25% of the shares will vest 30 months after the Issue Date and (iv) 25% of the shares will vest 36 months after the Issue Date, subject to the Reporting Person's continuous service through such dates.
AI-generated analysis. How Rhea-AI works. Not financial advice.
